History of cancer screening in the EU – Lung Cancer Policy Network
Lung Cancer Policy Network shared on LinkedIn:
“Following their involvement in a panel discussion at the 2024 European Congress of Radiology (European Society of Radiology), Eleanor Wheeler, Ritse Mann, Hein van Poppel and Mireille Broeders have written a blog about the history of cancer screening in the EU, and the advances that many hope will be catalysed following last year’s update of EU screening guidelines.
Looking at the current landscape for lung, breast and prostate cancer, the blog provides an overview of approaches to screening, and what the future holds.
Until last year, there was only one established imaging screening programme in Europe: mammography, for breast cancer.
Now there are two more where implementation is being considered and, in some cases, is already underway: low-dose computed tomography for lung cancer, and magnetic resonance imaging (MRI), which is used alongside laboratory tests, for prostate cancer.
We are also seeing a paradigm shift for screening, from a ‘one-size-fits-all’, population-based approach to a more personalised risk-based approach.
While there are challenges to address, evidence-based expansion of screening provision could be hugely beneficial.”